IRVINE, Calif.–(BUSINESS WIRE)–Sep. 2, 2016–
Masimo (NASDAQ:
MASI) today announced an amendment to the existing settlement agreement
initially reached between Masimo and Nellcor in January 2006. Under the
terms of the amendment, Medtronic will continue to pay Masimo a royalty
of 7.75% for its current pulse oximetry products sold in the United
States through October 6, 2018, after which no further royalties will be
due under the agreement. For more information, please see the related
Form 8-K filed with the Securities and Exchange Commission on September
2, 2016.

About Masimo

Masimo (NASDAQ: MASI) …

Más información: Masimo Announces Amendment to Nellcor Royalty Agreement